Clinical Trials Sponsored by John Kempen

Total 4215 results

John Kempen

Completed

Iontophoresis Delivery of Dexamethasone Phosphate for Non-infectious, Non-necrotizing Anterior Scleritis, Phase 1 Dose-varying Study

Non-infectious, Non-necrotizing Anterior Scleritis

United States
Thomas More Kempen

Unknown

Therapeutic Effects of a New Upper Limb Robot Assisted Therapy Device for Persons After Stroke (ARTHE)

Stroke

Belgium
Thomas More Kempen
AZ Herentals

Recruiting

Robot Assisted Gait Training in Persons With a Spinal Cord Injury

SCI - Spinal Cord Injury

Belgium
Thomas More Kempen
Ortho-Medico

Unknown

Active Smart Wearable Orthosis for Enhanched Rehabilitation THErapy (ARTHE)

Stroke

Belgium
Memgen, LLC

Completed

A Phase I Extension Trial of Repeated Infusions of ISF35

Chronic Lymphocytic Leukemia

United States
Memgen, LLC

Completed

A Phase I Trial of Autologous CLL B Cells Transduced to Express Chimeric CD154 (ISF35)

Chronic Lymphocytic Leukemia

United States
Zoé van Kempen

Completed

COVID-19 and SARS-CoV-2 Antibodies in Multiple Sclerosis Patients (COMS-19)

Multiple Sclerosis

Netherlands
Thomas More Kempen
Revalidatie & MS Centrum Overpelt

Unknown

Assessing Fatiguability of Tongue Muscles in MS

Multiple Sclerosis | Fatigue | Muscle Weakness | Deglutition Disorders | Exertion; Excess

Belgium
University Hospital, Basel, Switzerland
St. Clara Hospital, Basel, Switzerland; Klinikum Kempten, Kempten, Germany

Not yet recruiting

oPen Versus RobotIc retrOmuscular Repair in Medium to Large Ventral Hernias (PRIOR)

Ventral Hernia | Abdominal Wall Defect | Incisional Hernia
Lieven De Maesschalck
Handicap International

Completed

3D-printing and Acces to Tele Rehabilitation (Imp&acte3D)

Orthopedic Disorder

Mali, Niger, Togo
Klinikum Emden

Completed

Vitamine D in Post-COVID Patients (VD-PCS)

Post COVID

Germany
Kemin Foods LC

Completed

The Effect of XSurge Supplementation on Biomarkers and Performance From High Intensity Resistance Exercise

Exercise Performance Recovery

United States
Kemin Foods LC

Completed

Evaluation of the Benefits of FloraGLO™ Lutein on Skin Health

Healthy | Aging | Hydration | Wrinkle | Skin Elasticity

United States
Kemin Foods LC

Completed

Efficacy of a Whole Cell Algae Fermentate on Gut Health and Overall Immune Function in Healthy Adults With Mild Gastrointestinal Issues

Healthy | Gastrointestinal Dysfunction | Flu Symptom | Cold Symptom

United States
John Muir Health

Recruiting

Barotrauma in Hyperbaric Oxygen Therapy (HBOT)

Barotrauma

United States
Marks, John, M.D.

Terminated

Maintenance Chemotherapy After Neoadjuvant Chemoradiation Therapy for Distal Rectal Cancer

Rectal Neoplasms

United States
Elpen Pharmaceutical Co. Inc.

Recruiting

Ezetimibe-Rosuvastatin Evaluation Study (ZEUS)

Hypercholesterolemia | Hyperlipidemias | Combinations of Drugs; Dependence

Greece
Elpen Pharmaceutical Co. Inc.

Completed

A Retrospective rEal-life daTa Study to Assess the exaceRbations and Lung functIon in Chronic Obstructive Pulmonary Disease ( COPD ) patiEnts receiVing Fluticasone/Salmeterol Comparing to Those Εscalating in Open-triple Fluticasone/Salmeterol, Long Acting Muscarinic Antagonist (LAMA) Combination (RETRIEVE)

COPD | COPD Exacerbation

Greece
Elpen Pharmaceutical Co. Inc.

Completed

AdditioN of Fixed Dose Combination (FDC) Of Budesonide/Formoterol Via Elpenhaler® Device in Greek Patients With asThma accΟrding to Standard Clinical Practice. (NOTOS)

Asthma

Greece
Elpen Pharmaceutical Co. Inc.

Completed

Α Prospective Observational Study for the Evaluation of Disease Control and Quality of Life in Patients With Benign PROStatic hyPERplasia Under Fixed Dose combΙnaTion Treatment With Dutasteride and Tamsulosin . PROSPERITY Group of Studies (I&II) (PROSPERITY)

Benign Prostatic Hyperplasia

Greece
Elpen Pharmaceutical Co. Inc.

Completed

Efficacy and Safety Study of Fluticasone/Salmeterol Administered With Elpenhaler

Asthma
Elpen Pharmaceutical Co. Inc.

Completed

Evaluation of the Effectiveness and Quality of Life With the Administration of the Fixed Combination of Budesonide Formoterol in Greek Patients With Asthma During Routine Clinical Practice. (BOREAS)

Quality of Life | Asthma

Greece
Elpen Pharmaceutical Co. Inc.

Withdrawn

Clinical Study to Evaluate the Predictive Value of the Heart Failure Questionnaire (HF-Q) for the Occurrence of Μajor Αdverse Cardiovascular Events (MACE) in Patients With Symptomatic Heart Failure (THETIS)

Heart Failure | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure NYHA Class IV
Elpen Pharmaceutical Co. Inc.

Withdrawn

Predictive Factors for Successful Outcome After Pulmonary Veins Ablation to Treat Paroxysmal Atrial Fibrillation

Atrial Fibrillation

Greece
Elpen Pharmaceutical Co. Inc.

Completed

Prospective Study of the Evaluation of Disease contRol and the Quality of Life of Patients With depressiOn and With or Without aNxiety disOrders in the Greek populatIon (PRONOI)

Depression | Anxiety Disorders

Greece
Elpen Pharmaceutical Co. Inc.

Completed

10-day Versus 14-day Concomitant PAMC as First-line Treatment Strategy for the Eradication of H. Pylori Infection

Helicobacter Pylori Infection

Greece
Elpen Pharmaceutical Co. Inc.

Completed

Quality of Life Assessment in Greek asthmatIc Patients Treated With the Fixed Dose Combination of Budesonide / Formoterol in Clinical Practice (SKIRON)

Quality of Life | Asthma | Satisfaction

Greece
Elpen Pharmaceutical Co. Inc.

Completed

Clinical Trial in Patients With Hypertension and Left Ventricular Dysfunction

Hypertension | Diabetes Mellitus | Renal Insufficiency | Sleep Apnea | Cardiac Arrhythmias

Greece
Elpen Pharmaceutical Co. Inc.

Completed

LevetIracetam in Patients Being Treated for Epilepsy (LIBERTY)

Epilepsy

Greece
Elpen Pharmaceutical Co. Inc.

Completed

Antiplatelet Therapy Following Stent Implantation (Anti-Clot)

Angina, Unstable | Acute Myocardial Infarction | Coronary Syndrome

Greece
Elpen Pharmaceutical Co. Inc.

Completed

Atorvastatin Study in Cardiovascular Disease Risk (ANTLER)

Dyslipidemia | Hypercholesterolemia

Greece
Elpen Pharmaceutical Co. Inc.

Completed

BALLOON (Corticosteroid/laBA inhaLers in adoLescents' Asthma: Assessment Of Patients satisfactiON) Study (BALLOON)

Asthma

Greece
Elpen Pharmaceutical Co. Inc.

Completed

ADVANCE Study: Alzheimer Disease eVAluation iN Clinical PracticE (ADVANCE)

Dementia | Alzheimer Disease | Cognitive Disorders

Greece
John Hunter Hospital

Completed

Detection of Vascular Injury in Diabetes Through Eye and Nailfold Data (DIVIDEND) - A Pilot Study (DIVIDEND)

Type 1 Diabetes Mellitus

Australia
Jens Bräunlich

Recruiting

NHF vs. COT in Hypoxemic Pandemic Viral Illness (HIVI)

Hypercapnic Respiratory Failure | Hypoxemic Respiratory Failure | Acute Viral Bronchitis

Germany
Elpen Pharmaceutical Co. Inc.

Completed

Carvedilol Vascular Efficacy Trial (CARVEDIA)

Heart Failure | Acute Myocardial Infarction

Greece
Elpen Pharmaceutical Co. Inc.

Withdrawn

Improvement of Fatigue Symptoms in the Iron Deficiency Anemia With Iron Succinylate Therapy (IFAISTOS)

Fatigue | Iron-deficiency | Anemia | Iron Deficiency Anemia
Elpen Pharmaceutical Co. Inc.

Withdrawn

Adherence of Iron Succinylate Therapy in Pregnancy (ARTEMIS)

Pregnancy Related | Pregnancy Anemia | Iron Deficiency Anemia

Greece
Elpen Pharmaceutical Co. Inc.

Completed

Prospective evAluatIon foR Inhalation Devices Study (PAIR)

Asthma | COPD

Greece
Elpen Pharmaceutical Co. Inc.

Completed

Bosentan Treatment of Digital Ulcers Related to Systemic Sclerosis (GRegistry SCDU)

Scleroderma | Digital Ulcer | Systematic Sclerosis

Greece
Elpen Pharmaceutical Co. Inc.

Withdrawn

Efficacy and Safety of Upfront Combination of ΒΟsentan and ΤΑdalafil in Pulmonary Arterial Hypertension (BOTA-PAH)

Pulmonary Hypertension
Elpen Pharmaceutical Co. Inc.

Withdrawn

COlchicine for the Prevention of Post Electrical Cardioversion Recurrence of AF (COPPER-AF)

Atrial Fibrillation
Elpen Pharmaceutical Co. Inc.

Completed

Eplerenone in Heart Failure Treatment (INOSET)

Heart Failure | Hypertension | Acute Myocardial Infarction

Greece
Elpen Pharmaceutical Co. Inc.

Completed

Ekvasis of Atorvastatin (Antorcin®) Treatment in Patients With Acute Cardiovascular Events (EKVASIS)

Cardiovascular Disorders

Greece
Elpen Pharmaceutical Co. Inc.

Completed

ANASA (Patients' Satisfaction With Pulmonary Diseases' Treatment) (ANASA)

Chronic Obstructive Pulmonary Disease | Asthma

Greece
Elpen Pharmaceutical Co. Inc.

Not yet recruiting

QualiTy of Life Evaluation in Patients With ChRonic ObstructIve Pulmonary Disease Who Require Tiotropium as additiOnal treatmeNt. (TRITON)

COPD
Elpen Pharmaceutical Co. Inc.

Not yet recruiting

TorasEmide Induced Effect on Quality of Life and Clinical parameterS in paTients With chronIc heArt Failure Receiving Eplerenone. (ESTIA)

Chronic Heart Failure
Elpen Pharmaceutical Co. Inc.

Recruiting

Clinical Study for the Effectiveness of Roflumilast Treatment in COPD Greek Patients Based on Standard Clinical Practice. (ARGO)

Copd | COPD Exacerbation

Greece
Elpen Pharmaceutical Co. Inc.

Recruiting

Effectiveness of Bosentan Therapy in Patients With Systemic scleRosis and Progressive Digital ulcEr Disease. (CURE)

Autoimmune Diseases | Diffuse Cutaneous Systemic Sclerosis | Scleroderma | Digital Ulcer | Reynold Syndrome

Greece
Jens Bräunlich

Recruiting

Ultrasonographic Evaluation of the Diaphragm During NHF Versus NIV Use in Respiratory Failure (SENNI)

Diaphragm Issues | Respiratory Failure With Hypoxia | Respiratory Failure With Hypercapnia | Non-invasive Mechanical Ventilation

Germany

3

Subscribe